Dermatol. praxi. 2024;18(1):48-51 | DOI: 10.36290/der.2024.008

Possibilities of pharmacological and surgical treatment of hidradenitis suppurativa

MUDr. Júlia Bartková, MBA1, 2, 3, Ema Šutaková4, Miroslava Verbat5, Dominika Miklišová3, prof. MUDr. Břetislav Lipový, Ph.D., MBA, LL.M.2
1 Klinika popáleninové medicíny, 3. lekárska fakulta, Univerzita Karlova, Praha Fakultná nemocnica Královské Vinohrady, Praha
2 Klinika popálenin a plastické chirurgie Lékařské fakulty Masarykovy univerzity a Fakultní nemocnice Brno
3 Lekárska fakulta Masarykovej univerzity, Brno
4 II. lekárska fakulta, Univerzita Karlova, Praha
5 I. lekárska fakulta, Univerzita Karlova, Praha

Hidradenitis suppurativa (HS) is difficult to diagnose and often refractory to conventional treatment which make its treatment and management very challenging for clinicians. The treatment option can vary according to the stage of the disease. For each patient, proper education is recommended, including options for conservative treatment, psychosocial support, options for pain relief, and treatment of suppurative manifestations with the application of appropriate wound coverage. To achieve minimal recurrence, surgical therapy has its place at every stage of the disease. A multidisciplinary approach including mainly dermatologist and plastic surgeon is key to prompt optimal disease control.

Keywords: Hidradenitis suppurativa, autotransplantation, reconstruction of the axilla, skin graft, treatment.

Accepted: March 26, 2024; Published: April 3, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartková J, Šutaková E, Verbat M, Miklišová D, Lipový B. Possibilities of pharmacological and surgical treatment of hidradenitis suppurativa. Dermatol. praxi. 2024;18(1):48-51. doi: 10.36290/der.2024.008.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. García-Sánchez MA, Santillan-Arellano EG. Verneuil's disease: A case report and literature review. Rev Gastroenterol Mex. 2015;80(3):225-227. doi: 10.1016/j.rgmx.2015.02.002. Go to original source... Go to PubMed...
    2. Ocker L, Abu Rached N, Seifert C, et al. Current Medical and Surgical Treatment of Hidradenitis Suppurativa-A Comprehensive Review. J Clin Med. 2022;11(23):7240. doi: 10.3390/jcm11237240. Go to original source... Go to PubMed...
    3. Kokolakis G, Wolk K, Schneider-Burrus S, et al. Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System. Dermatology. 2020;236(5):421-430. doi: 10.1159/0005087874. Go to original source...
    4. Šutáková E, Miklišová D, Verbat M, et al. Surgical management of hidradenitis suppurativa In: PlastSurgeon.com [Internet]. 2023 May [cited 2023 Jul 22]. Available from: https://plastsurgeon.com/case-competition-overview/case-competition-2023/case-18-surgical-management-of-hidradenitis-suppurativa/.
    5. Jfri A, Nassim D, O'Brien E, et al. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis. JAMA Dermatol. 2021;157(8):924-931. doi: 10.1001/jamadermatol.2021.1677. Go to original source... Go to PubMed...
    6. Amat-Samaranch V, Agut-Busquet E, Vilarrasa E, et al. New perspectives on the treatment of hidradenitis suppurativa. Ther Adv Chronic Dis. 2021;12:20406223211055920. doi: 10.1177/20406223211055920. Go to original source... Go to PubMed...
    7. Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29(4):619-644. doi: 10.1111/jdv.12966. Go to original source... Go to PubMed...
    8. Amat-Samaranch V, Agut-Busquet E, Vilarrasa E, et al. New perspectives on the treatment of hidradenitis suppurativa. Ther Adv Chronic Dis. 2021;12:20406223211055920. doi: 10.1177/20406223211055920. Go to original source... Go to PubMed...
    9. Timila Touhouche A, Chaput B, Marie Rouquet R, et al. Integrated multidisciplinary approach to hidradenitis suppurativa in clinical practice. Int J Womens Dermatol. 2020;6(3):164-168. doi: 10.1016/j.ijwd.2020.02.006. Go to original source... Go to PubMed...
    10. Heymann WR. Resorcinol's resourcefulness in hidradenitis suppurativa. American Academy of Dermatology. 2023;5(12).
    11. Docampo-Simón A, Beltrá-Picó I, Sánchez-Pujol MJ, et al. Topical 15% Resorcinol Is Associated with High Treatment Satisfaction in Patients with Mild to Moderate Hidradenitis Suppurativa. Dermatology. 2022;238(1):82-85. doi: 10.1159/000515450. Epub 2021 Apr 22. PMID: 33887735. Go to original source... Go to PubMed...
    12. Buchanan L. Market Study Reports Secukinumab Emerged as a Leading Treatment for HS. Dermatology Times. Available from: https://www.dermatologytimes.com/view/market-study-reports-secukinumab-emerged-as-a-leading-treatment-for-hs.
    13. Martorell A, Jfri A, Koster SBL, et al. Defining hidradenitis suppurativa phenotypes based on the elementary lesion pattern: results of a prospective study. J Eur Acad Dermatol Venereol. 2020;34(6):1309-1318. doi: 10.1111/jdv.16183. Epub 2020 Feb 16. PMID: 31919904. Go to original source... Go to PubMed...
    14. Blanco R, Martínez-Taboada VM, Villa I, et al. Long-term successful adalimumab therapy in severe hidradenitis suppurativa. Arch Dermatol. 2009;145(5):580-584. doi: 10.1001/archdermatol.2009.49. Go to original source... Go to PubMed...
    15. Ingram JR, Collier F, Brown D, et al. British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018. Br J Dermatol. 2019;180(5):1009-1017. doi: 10.1111/bjd.17537. Go to original source... Go to PubMed...
    16. Shukla R, Karagaiah P, Patil A, et al. Surgical Treatment in Hidradenitis Suppurativa. J Clin Med. 2022;11(9):2311. doi:10.3390/jcm11092311. Go to original source... Go to PubMed...
    17. Machado MO, Stergiopoulos V, Maes M, et al. Depression and Anxiety in Adults With Hidradenitis Suppurativa: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019;155(8):939-945. doi: 10.1001/jamadermatol.2019.0759. Go to original source... Go to PubMed...
    18. Manfredini M, Garbarino F, Bigi L, et al. Hidradenitis Suppurativa: Surgical and Postsurgical Management. Skin Appendage Disord. 2020;6(4):195-201. doi: 10.1159/000507297. Go to original source... Go to PubMed...
    19. Sugio Y, Tomita K, Hosokawa K. Reconstruction after Excision of Hidradenitis Suppurativa: Are Skin Grafts Better than Flaps? Plast Reconstr Surg Glob Open. 2016;4(11):e1128. doi:10.1097/GOX.0000000000001128. Go to original source... Go to PubMed...
    20. Verbat M, Šutáková E, Miklišová D, et al. Introduction to Hidradenitis Suppurativa. In: PlastSurgeon.com [Internet]. 2023 Jul [cited 2023 Jul 22]. Available from: https://plastsurgeon.com/wound-management/hidradenitis-suppurativa/introduction-to-hidradenitis-suppurativa/.

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.